Health Care

2392 posts

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.

PharmaDrug-PharmaTher Holdings JV submits clinical, regulatory package

Sairiyo Therapeutics, a PharmaDrug (CSE:PHRX) and PharmaTher Holdings (CSE:PHRM) joint venture, pursues a human clinical study in Australia.

WELL Health and Microsoft to future-proof North American healthcare

WELL Health Technologies (TSX:WELL) and Microsoft (NDAQ:MSFT) sign a five-year deal to expedite healthcare's transition into the digital age.

Sona Nanotech reveals results from breast cancer study

Sona Nanotech (CSE:SONA) reveals additional results from the triple-negative breast cancer murine model portion of its research study.

Calian scores $23 million Canadian Armed Forces contract

Calian Group Ltd. (TSX:CGY) has been awarded a $17 million contract by the Canadian Armed Forces’ Canadian Forces Health Services Group.

This life sciences company is gearing up to treat long COVID  

Revive Therapeutics (CSE:RVV), a Toronto-based company, has immense potential to capitalize on treating long COVID symptoms.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

Canada’s federal budget: What investors need to know

Canada’s federal budget in has sent ripples through the investor community, revealing shifts in fiscal policies and spending priorities.

Canadian biotech stock investigates potential weight loss drugs

FSD Pharma Inc. (CSE:HUGE) is expanding its pipeline into metabolic and related disorders including weight loss and liver health.

Kane Biotech to sell its STEM Animal Health for C$11.5 million

Kane Biotech (TSXV:KNE) is selling its entire interest in STEM Animal Health to a third-party pharmaceutical company for C$11.5 million.

Cannabis stock jumps on news its products are coming to Canada

Ovation Science Inc. (CSE:OVAT) signs an exclusive licensing agreement for its products in Canada with Ripco Processing Inc.
The Market Online Video

Emerging opportunity in a growing, high-value dermatological market

Kane Biotech (TSXV:KNE) engages in the development and commercialization of products that prevent and remove microbial biofilms.

Buzz on the Bullboards: Looking for volatility-proof stocks?

Investors saw developments in Canadian and U.S. stock markets, with attention on decisions made by central banks and moves in key sectors.

Medicenna shares preclinical data on treatment targeting tumours

Medicenna Therapeutics revealed new preclinical data from its MDNA113 drug candidate, the company's treatment targeting IL-13Ra2.

Red Light Holland reports record psilocybin shipment

Psychedelics stock Red Light Holland (CSE:TRIP) exports 5 kilograms of natural psilocybin truffles to CCrest Laboratories in Montreal.